-
Avalon Tech
2,171.00 778.15(%) -
Bharti Airtel
1,753.30 1,745.00(%) -
NSE
1,761.00 1,761.00(%) -
Molbio Diagnosti
1,368.00 1,686.50(%) -
Apollo Hospitals
8,063.00 6,680.00(%) -
Innova Captab
1,080.00 608.25(%) -
Hero Motors
152.58 156.03(%) -
Meesho
230.55 254.65(%) -
Azad Engineering
3,126.00 3,126.00(%) -
Shadowfax Technologies
278.10 98.60(%) -
Cupid
312.10 312.10(%) -
L&T Finance Ltd
264.75 234.90(%) -
Lenskart Solut.
698.00 725.00(%) -
Reliance Industries
1,196.30 1,611.20(%) -
SS Retail
761.45 888.00(%) -
Sun TV Network
664.60 664.60(%) -
Solar Industries
19,820.00 22,630.05(%) -
PB Fintech.
1,040.00 1,040.00(%) -
National High
168.00 142.00(%) -
HDFC Bank
709.70 682.00(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Citurgia Biochemicals Ltd Chemicals
- MNC Associate
- BSE Code : 115.0
- ISIN : INE795B01031
-
Today’s Low
104.45 -
Today’s High
105.50
-
Open
105.50 -
Perv Close
105.50 -
52W Low
47.40 -
52W High
212.00
Key Indicators
-
P/E(TTM)
0.00
-
Mar.Cap (₹Cr.)
1,379.74
-
Div & Yield %
0.00
-
Book Value(₹)
-0.77
-
Debt-Equity Ratio
-1.00
-
AGM Date
28-Sep-2026
-
EPS
0.00
-
P/E Ratio
0.00
Financials Ratios
-
Debt-Equity Ratio
-
-
Mar.Cap (₹Cr.)
1,379.74
-
RONW (%)
-
-
ROCE (%)
-
Score Board
-
Equity (₹ in Cr.)
26.42
-
BV (₹)
-0.80
-
Sales( ₹ in Cr.)
0.00
-
NP (in Cr.)
-0.74
-
NP Var(%)
-75.0
-
Div%
0.0
-
CPS (₹)
0.00
-
EPS (₹)
-0.10
-
Traded Value (₹ in Lakhs)
1,379.74
-
52 Week High
212.00
-
52 Week Low
47.40
-
Price BSE
104.0
-
Price NSE
4.00
-
Market Capital( in Cr.)
1,379.74
-
P/C Ratio
-2,657.80
-
P/E Ratio
-1,850.20
-
Price Vs.BV
-0.10
-
30-Sep-2026( 02:24)
Corporate News - Citur... - <p>Citurgia Biochemicals Limit...
-
18-Sep-2026( 06:07)
Corporate News - Citur... - <p>Citurgia Biochemicals Limit...
-
04-Aug-2026( 04:40)
Corporate News - Citur... - Citurgia Biochemicals Limited...
-
01-Jun-2026( 07:27)
Results - Announcements - Citur... - Net Loss of Citurgia Biochemic...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EXPENDITURE : | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Power and Fuel Cost | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Employee Cost | 0.17 | 0.17 | 0.16 | 0.16 | 0.14 | 0.10 |
| Other Manufacturing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling and Administration Expenses | 0.02 | 0.08 | 0.04 | 0.02 | 0.23 | 0.01 |
| Miscellaneous Expenses | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Employee Benefit Expenses | 0.17 | 0.17 | 0.16 | 0.16 | 0.14 | 0.10 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 0.20 | 0.25 | 0.21 | 0.18 | 0.37 | 0.12 |
| Operating Profit | -0.20 | -0.25 | -0.21 | -0.18 | -0.37 | -0.12 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -0.20 | -0.25 | -0.21 | -0.18 | -0.37 | -0.12 |
| Depreciation | 0.23 | 0.23 | 0.23 | 0.23 | 0.24 | 0.28 |
| Profit Before Tax | -0.43 | -0.48 | -0.44 | -0.41 | -0.61 | -0.40 |
| Current Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Net Profit | -0.42 | -0.48 | -0.44 | -0.40 | -0.61 | -0.40 |
| Extraordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Net Profit | -0.42 | -0.48 | -0.44 | -0.40 | -0.61 | -0.40 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance brought forward | -35.56 | -35.09 | -34.65 | -34.25 | -33.63 | -33.24 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | -35.98 | -35.56 | -35.09 | -34.65 | -34.25 | -33.63 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | -0.16 | -0.18 | -0.17 | -0.15 | -0.23 | -0.15 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - | - |
| Book Value | -3.59 | -3.43 | -3.25 | -3.09 | -2.93 | -2.70 |
| Book Value(Adj)-Unit Curr | - | - | - | - | - | - |
